Rapt Therapeutics, Inc. (RAPT)
57.61
+0.04
(+0.07%)
USD |
NASDAQ |
Jan 21, 10:58
Rapt Therapeutics Price: 57.61 for Jan. 21, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Replimune Group, Inc. | 6.98 |
| Olema Pharmaceuticals, Inc. | 26.61 |
| NovaBay Pharmaceuticals, Inc. | 5.67 |
| Palatin Technologies, Inc. | 16.98 |
| Theriva Biologics, Inc. | 0.1932 |
Price Related Metrics
| PEG Ratio | -0.0197 |
| Price to Book Value | 6.269 |
| Earnings Yield | -18.24% |
| Market Cap | 952.74M |
| PEGY Ratio | -0.0197 |